Stirlingshire Investments, Inc.

Position in NVS — Novartis AG

CIK 1829271 NEW YORK, NY

Position in NVS

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$310,148

+$57,653 QoQ

Shares Held

1,979

+19.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.69%

of 13F equity value

Holder Rank

#1,113

of 1,603 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Stirlingshire Investments, Inc. holds $1,780,387 across 5 Drug Manufacturers - General names. NVS ranks #4 (17.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	1,998	$507,432
2	MRK	Merck & Co., Inc.	2,923	$375,605
3	LLY	ELI LILLY & Co	289	$346,635
4	NVS	Novartis AG This page	1,979	$310,148
5	ABBV	AbbVie Inc.	956	$240,567

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$310,148	1,979	+19.7%	Shares	Sole	2026-07-31
2026-03-31	$252,495	1,653	—	Shares	Sole	2026-05-04
No filing history on record for this holder in this stock.